Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
| Revenue (Most Recent Fiscal Year) | $1.70B |
| Net Income (Most Recent Fiscal Year) | $-190.43M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 11.73 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 18.40 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -12.90% |
| Net Margin (Trailing 12 Months) | -12.89% |
| Return on Equity (Trailing 12 Months) | -22.22% |
| Return on Assets (Trailing 12 Months) | -15.03% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.72 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.58 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 14.73 |
| Book Value per Share (Most Recent Fiscal Quarter) | $9.08 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.74 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.53 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.91 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 137.25M |
| Free Float | 129.52M |
| Market Capitalization | $23.04B |
| Average Volume (Last 20 Days) | 1.54M |
| Beta (Past 60 Months) | 1.76 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 5.63% |
| Percentage Held By Institutions (Latest 13F Reports) | 99.90% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |